Keyphrases
Bacteremia
45%
Endocarditis
42%
Cryptococcus Gattii
38%
Early Clinical Exposure
38%
HIV-associated Lymphoma
38%
Delafloxacin
38%
Texas
38%
Erysipelothrix Rhusiopathiae
38%
Fish Handlers
38%
Fungal Infection
38%
Meningitis
38%
Cryptococcal Osteomyelitis
38%
Novel Antibiotics
38%
Cryptococcal Infection
38%
Valve Endocarditis
38%
Immune Reconstitution
38%
Viral Load
38%
CD4 Count
38%
Antibiotic Combination
38%
Eustachian Valve
38%
Nosocomial Pneumonia
38%
Carbapenem-resistant Acinetobacter Baumannii
38%
Lymphoma Diagnosis
31%
Immune System
25%
Staphylococcus Epidermidis (S. epidermidis)
22%
Gattii
19%
Early Recognition
19%
Severe Infection
19%
40 Years Old
19%
Immunocompetent Individual
19%
Early Treatment
19%
Non-endemic
19%
Disease Progression
19%
Cefiderocol
19%
Autopsy
19%
Young Males
19%
Development Effort
19%
Septic Shock
19%
Extensively Drug-resistant
19%
Drug Development
19%
Poor Outcome
19%
Expanded Access
19%
Nosocomial Infection
19%
Acinetobacter Baumannii (A. baumannii)
19%
Baumannii
19%
Pneumonia
19%
Oncology Clinic
15%
HIV Patients
15%
Downtrend
15%
Infectious Complications
15%
Medicine and Dentistry
Infection
100%
Endocarditis
77%
Human Immunodeficiency Virus
58%
Bloodstream Infection
47%
Mycosis
38%
Osteomyelitis
38%
Erysipelothrix rhusiopathiae
38%
Delafloxacin
38%
Meningitis
38%
Immune Reconstitution Inflammatory Syndrome
38%
Cryptococcus gattii
38%
Acinetobacter Baumannii
38%
Antimicrobial Agent
38%
Immune System
25%
Disease Exacerbation
19%
Cefiderocol
19%
Awareness
19%
Septic Shock
19%
Hospital Infection
19%
Diseases
19%
Penicillin
19%
Oral
16%
Quinolone Derivative
14%
Staphylococcus Epidermidis
13%
Methicillin-Resistant Staphylococcus Epidermidis
12%
Conservative Treatment
12%
Secondary Infection
12%
Nervous System
12%
Side Effect
11%
Ceftriaxone
9%
Pathogenic Organism
9%
Valve Replacement
9%
Mitral Valve
9%
Gram-Positive Bacteria
9%
Aortic Valve
9%
Congestive Heart Failure
9%
Oncology
7%
Infectious Complication
7%
Lymphocyte
7%
Cryptococcosis
6%
Human Immunodeficiency Virus Infection
6%
Pharmacology, Toxicology and Pharmaceutical Science
Infection
53%
Delafloxacin
38%
Acinetobacter Baumannii
38%
Endocarditis
38%
Antibiotic Agent
38%
Cryptococcus gattii
38%
Meningitis
38%
Erysipelothrix rhusiopathiae
38%
Mycosis
38%
Bloodstream Infection
38%
Antimicrobial Agent
38%
Diseases
24%
Disease Exacerbation
19%
Septic Shock
19%
Hospital Infection
19%
Drug Development
19%
Cefiderocol
19%
Penicillin
19%
Quinolone Derivative
14%
Gram Positive Bacterium
9%
Ceftriaxone
9%
Congestive Heart Failure
9%